Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Webcast

Silverback Therapeutics to Participate in the H.C. Wainwright Hepatitis B Virus (HBV) Conference


Silverback Therapeutics, Inc. (Nasdaq: SBTX) ("Silverback"), a clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases, today announced that the Company will participate in the H.C. Wainwright Hepatitis B Virus (HBV) Conference on Wednesday, October 13, 2021.

Laura Shawver, Ph.D., Silverback's Chief Executive Officer, and Valerie Odegard, Ph.D., Silverback's President and Chief Scientific Officer, will participate in a fireside chat on Wednesday, October 13, 2021, at 10:30 a.m. ET (7:30 a.m. PT). The live webcast of the presentation will be available on Silverback's investor relations website.

About Silverback Therapeutics

Silverback Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered and tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. Silverback's platform enables the strategic pairing of proprietary payloads that modulate key disease modifying pathways with monoclonal antibodies directed at specific disease sites. Initially, Silverback is creating a new class of targeted immuno-oncology agents that direct a TLR8 agonist myeloid cell activator to the tumor microenvironment in solid tumors to promote cancer cell killing. Silverback Therapeutics is located in Seattle, Washington. To learn more, visit www.silverbacktx.com.


These press releases may also interest you

at 14:00
Allina Health | Aetna, a joint venture health care company owned by Allina Health and Aetna®, a CVS Health® company, is dedicated to providing its members with quality care and coverage. As health insurance adapts and changes to a post-Covid world,...

at 14:00
Johnson & Quin, a leading direct mail services provider for over 40 years, today announced the successful completion of their System and Organizational Controls (SOC) 2® Type 2 examination and HIPAA security compliance assessment. These achievements...

at 13:50
Everybody deserves the right to smile, whatever your ability or disability. That's the message Project Accessible Oral Health (PAOH) wants to send loud and clear on behalf of people with intellectual and developmental disabilities (IDD), their...

at 13:49
At a time when most countries still maintain a tough legal regime prohibiting the use and supply of cannabis, NEKTR token is joining forces with other pro-cannabis communities to spread awareness about its potential health benefits. With its upcoming...

at 13:45
Scipher Medicine, a precision immunology company matching patients with their most effective therapy, today announced the appointment of Michael Elliott, MBBS, PhD, FRACP, as scientific advisor. Dr. Elliott is a physician-scientist and pioneer in...

at 13:45
The "Endocrine Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global endocrine testing market reached a value of US$ 10 Billion in...



News published on 5 october 2021 at 08:05 and distributed by: